PATENT CLAIM ANALYSIS

Application Number: 15750128
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-08
Patent Classification: ["514", "412000"]

Abstract:
The disclosure provides compounds having formula (I), wherein the substituents are as defined herein. The compounds are useful for modulating the dopamine D 3  receptor and for treating conditions associated therewith, such as addictions, drug dependency, and psychiatric conditions.

Claim (Index 17):
The compound of  claim 16  having formula (IXA) or (IXB).

Metadata:
- Claim Count in Document: 16.0
- Percentile: 88.0
- Lexical Diversity: 1.34286
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15583679', '15272114', '13613344', '12664394', '11911035']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.83193114234183
- 35 USC 102 Novelty (BERT): 0.5477485416559964
- Combined Prediction Score: 0.8035128822732467
- Mean Citation Score: 389.650642
- Max Citation Score: 434.1038
- Similarity Product: 270.5126588149548

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test